DLX4 hypermethylation is a prognostically adverse indicator in de novo acute myeloid leukemia.

about

Low NKD1 expression predicts adverse prognosis in cytogenetically normal acute myeloid leukemia.Epigenetic dysregulation of ID4 predicts disease progression and treatment outcome in myeloid malignancies.Homeobox transcription factor DLX4 is not necessary for skin development and homeostasis.

P2860

Q38819676-5864E38B-0FDF-4008-BA80-B1BE84CB996E Q41241298-A972AECA-0CE6-4011-B857-31D43E330ECB Q49586478-CBA75428-CDE3-4B71-ABA9-D3D7B7065E47

P2860

DLX4 hypermethylation is a prognostically adverse indicator in de novo acute myeloid leukemia.

Item

http://www.wikidata.org/entity/Q38804780

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

DLX4 hypermethylation is a pro ...... e novo acute myeloid leukemia.

@en

type

Item

label

DLX4 hypermethylation is a pro ...... e novo acute myeloid leukemia.

@en

prefLabel

DLX4 hypermethylation is a pro ...... e novo acute myeloid leukemia.

@en

P1476

DLX4 hypermethylation is a pro ...... e novo acute myeloid leukemia.

@en

P2093

Dong-Qin Yang

http://www.w3.org/2001/XMLSchema#string

Ji-Chun Ma

http://www.w3.org/2001/XMLSchema#string

Jiang Lin

http://www.w3.org/2001/XMLSchema#string

Jing Yang

http://www.w3.org/2001/XMLSchema#string

Jing-Dong Zhou

http://www.w3.org/2001/XMLSchema#string

Jun Qian

http://www.w3.org/2001/XMLSchema#string

Lei Yang

http://www.w3.org/2001/XMLSchema#string

Ting-Juan Zhang

http://www.w3.org/2001/XMLSchema#string

Xiang-Mei Wen

http://www.w3.org/2001/XMLSchema#string

Yu-Xin Wang

http://www.w3.org/2001/XMLSchema#string

P2860

BP1, a new homeobox gene, is frequently expressed in acute leukemias

Homeodomain protein DLX4 counteracts key transcriptional control mechanisms of the TGF-β cytostatic program and blocks the antiproliferative effect of TGF-β

BP1 is a negative modulator of definitive erythropoiesis

IDH1 and IDH2 mutation analysis in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome.

U2AF1 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome.

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

Identification of a metastasis signature and the DLX4 homeobox protein as a regulator of metastasis by combined transcriptome approach

The role of mutations in epigenetic regulators in myeloid malignancies.

Recurrent DNMT3A R882 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome.

DNA methylation biomarkers for lung cancer.

P2888

s13277-015-4364-4

P304

8951-8960

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13277-015-4364-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1013752399

http://www.w3.org/2001/XMLSchema#string

P698

26753961

http://www.w3.org/2001/XMLSchema#string

DLX4 hypermethylation is a prognostically adverse indicator in de novo acute myeloid leukemia.

about

P2860

P2860

DLX4 hypermethylation is a prognostically adverse indicator in de novo acute myeloid leukemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698